Overview

Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)

Status:
Active, not recruiting
Trial end date:
2022-12-19
Target enrollment:
Participant gender:
Summary
This study project includes a single-arm phase 2 study and a parallel cohort study, enrolling patients with COVID-19 pneumonia.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Institute, Naples